NMPA Approval

Amlodipine Besilate and Benazepril Hydrochloride Capsules

Approval Number

国药准字H20233691

Company扬子江药业集团广州海瑞药业有限公司

Registration Date

June 7, 2023

Drug Information

Generic Name

氨氯地平贝那普利胶囊

Dosage Form

胶囊剂

Strength

每粒含苯磺酸氨氯地平5mg（按氨氯地平计）与盐酸贝那普利10mg

Drug Type

化学药品

Registration Date

June 7, 2023

Company Information

Applicant Company

Company Name扬子江药业集团广州海瑞药业有限公司

Company Address

广州高新技术产业开发区广州科学城香山路31号

Manufacturing Company

Company Name扬子江药业集团广州海瑞药业有限公司

Company Address

广州高新技术产业开发区广州科学城香山路31号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

氨氯地平贝那普利胶囊 - NMPA 批准文号 | MedPath